Cannabis Regulators Speak Out on Key Issues Affecting Growers
February 26, 2021 The Cannabis Regulators Association recently sent a letter to the 117th Congress offering the association’s collective experience and expertise to federal officials as they contemplate changes to federal cannabis policy. The letter also contains an overview of key regulatory issues that impact state and federal cannabis priorities and warrant additional consideration from members of the U.S. House and Senate.
Here’s a sampling of what’s in the letter:
“The purpose of this letter is to introduce our association as a resource, so that interested members of Congress may benefit from the regulatory and implementation experiences of our members and the states they represent, and to provide a regulatory perspective on federal cannabis legislation. States across the country continue to experiment with new and changing cannabis policy. Each of the 36 states and four territories that have legalized some form of cannabis, whether they permit the use of cannabis by patients to treat qualifying medical conditions, use by adults age 21 and older, or both, has its own unique regulatory framework. Licensed activities, tax mechanisms and rates, market structure, the role of local governments, marketing and advertising, approved qualifying medical conditions, and many more regulatory issues vary greatly between jurisdictions. As an association, we are able to bring states together, even with varying regulatory frameworks, to discuss shared challenges and identify best practices in cannabis regulation.”
Among the key issues the association wants to bring to the attention of lawmakers include:
- Protections for state legalization frameworks
- Access to banking and traditional financial services
- Research and clinical knowledge
- Social and economic equity
- Consumer and product safety standards
- Laboratory testing standards
- Public health surveillance data
- Federal tax structure
Read the full letter here.
Subscribe to eNewsletter
